Implant Type
dbs
Electrodes
8
Channels
8
FDA Status
PMA-approved
Clinical Stage
Post-market (FDA PMA approved 2021)
Status
approved
About
The Boston Scientific Vercise Genus is a directional DBS system featuring a rechargeable neurostimulator with multi-source current control — each electrode contact can be driven by an independent current source, enabling precise spatial steering of the therapeutic field. The system integrates with Neural Navigator programming software, supports Qi wireless charging, and pairs with the GUIDE XT imaging visualization tool for precise lead placement planning. Supports both constant voltage and constant current stimulation modes.
Target Conditions
Parkinson's diseaseessential tremor
FDA Regulatory Pathway
No FDA Regulatory Status
This device does not have a current FDA designation. It may be a research tool, preclinical device, or consumer product not subject to FDA medical device regulation.
FDA Device Regulatory Guidance ↗